Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
June-2026 Volume 57 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2026 Volume 57 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review)

  • Authors:
    • Haiyan Li
    • Hongjuan Zhang
    • Hujun Zhang
    • Yujie Li
    • Yigang He
    • Jia Luan
  • View Affiliations / Copyright

    Affiliations: Department of Blood Transfusion, The 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou, Gansu 730000, P.R. China, Department of Neurology, General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China, Minimally Invasive Department, Lanzhou Time Laser Plastic and Aesthetic Hospital, Lanzhou, Gansu 730000, P.R. China, Health Examination Center, The 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou, Gansu 730000, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 164
    |
    Published online on: April 17, 2026
       https://doi.org/10.3892/ijmm.2026.5835
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

High‑altitude polycythemia (HAP) is classically attributed to erythropoietin (EPO)‑driven erythrocytosis, yet epidemiological and mechanistic evidence increasingly challenges this monocular view. Field data have demonstrated that up to 40% of individuals with a hematocrit level >68% circulate EPO within the sea‑level reference range, whereas multi‑omics studies have revealed sustained HIF activity, mitochondrial oxidative stress, iron dysregulation, gut dysbiosis and epigenetic reprogramming as parallel, EPO‑independent drivers. Hypoxia‑inducible microRNAs, hepcidin suppression, TLR4‑IL‑6 signaling and defective mitophagy converge to lock erythroid precursors into a survival‑plus‑proliferation state even after ambient oxygen levels normalize. The purpose of the present review is to integrate these disparate pathways into a unified molecular framework and to outline a phased, biomarker‑guided therapeutic roadmap for the precise prevention of maladaptive polycythemia at high altitudes.
View Figures

Figure 1

Erythropoietin-independent HIF
signaling networks in high-altitude polycythemia (www.figdraw.com). HIF, hypoxia-inducible factor; miR,
microRNA; HRE, hypoxia-responsive element.

Figure 2

Hypoxia-driven iron homeostasis
reprogramming: Central role of hepcidin-Fpn axis (www.figdraw.com). HIF, hypoxia-inducible factor; Fpn,
ferroportin; EPO, erythropoietin.

Figure 3

Microbiota-driven erythropoiesis:
TLR4-IL-6 hypoxia amplification loop (www.figdraw.com). LPS, lipopolysaccharide.
View References

1 

Villafuerte FC and Corante N: Chronic mountain sickness: Clinical aspects, etiology, management, and treatment. High Alt Med Biol. 17:61–99. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Gatterer H, Villafuerte FC, Ulrich S, Bhandari SS, Keyes LE and Burtscher M: Altitude illnesses. Nat Rev Dis Primers. 10:432024. View Article : Google Scholar : PubMed/NCBI

3 

Yang SH, Li B, Gao L and Li NH: Prevalence and risk factors of chronic mountain sickness in Pamirs plateau. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 34:336–339. 2018.In Chinese.

4 

Hancco I, Bailly S, Baillieul S, Doutreleau S, Germain M, Pépin JL and Verges S: Excessive erythrocytosis and chronic mountain sickness in dwellers of the highest city in the world. Front Physiol. 11:7732020. View Article : Google Scholar : PubMed/NCBI

5 

Song Z, Zhang A, Luo J, Xiong G, Peng H, Zhou R, Li Y, Xu H, Li Z, Zhao W and Zhang H: Prevalence of high-altitude polycythemia and hyperuricemia and risk factors for hyperuricemia in high-altitude immigrants. High Alt Med Biol. 24:132–138. 2023. View Article : Google Scholar : PubMed/NCBI

6 

Zila-Velasque JP, Grados-Espinoza P, Goicochea-Romero PA, Tapia-Sequeiros G, Pascual-Aguilar JE, Ruiz-Yaringaño AJ, Barros-Sevillano S, Ayca-Mendoza J and Nieto-Gutierrez W: Mountain sickness in altitude inhabitants of Latin America: A systematic review and meta-analysis. PLoS One. 19:e03056512024. View Article : Google Scholar : PubMed/NCBI

7 

Basang Z, Zhang S, Ke X, Duoji Z, Yang L, Qiangba D, De Y, Gesang D, Hu Z, Ma Y, et al: Differences in pathogenetic mechanism between tibetan and han high-altitude polycythemia based on a whole genome-wide association study. Phenomics. 5:169–182. 2025. View Article : Google Scholar : PubMed/NCBI

8 

Bao H, Wang D, Zhao X, Wu Y, Yin G, Meng L, Wang F, Ma L, Hackett P and Ge RL: Cerebral edema in chronic mountain sickness: A new finding. Sci Rep. 7:432242017. View Article : Google Scholar : PubMed/NCBI

9 

Yin R, Wu Y, Li M, Liu C, Pu X and Yi W: Association between high-altitude polycythemia and hypertension: A cross-sectional study in adults at Tibetan ultrahigh altitudes. J Hum Hypertens. 38:555–560. 2024. View Article : Google Scholar : PubMed/NCBI

10 

Bailey DM, Brugniaux JV, Filipponi T, Marley CJ, Stacey B, Soria R, Rimoldi SF, Cerny D, Rexhaj E, Pratali L, et al: Exaggerated systemic oxidative-inflammatory-nitrosative stress in chronic mountain sickness is associated with cognitive decline and depression. J Physiol. 597:611–629. 2019. View Article : Google Scholar

11 

Mima D, Wang LP, Zhai Y, De Q, Ba S, Da G, Wang BY, Zhao JB and Tang Y: Prevalence and risk factors for dementia in the Tibetan region: A population-based cross-sectional study. J Affect Disord. 334:159–165. 2023. View Article : Google Scholar : PubMed/NCBI

12 

Wang Z, Tenzing N, Xu Q, Liu H, Ye Y, Wen Y, Wuren T and Cui S: Apoptosis is one cause of thrombocytopenia in patients with high-altitude polycythemia. Platelets. 34:21573812023. View Article : Google Scholar : PubMed/NCBI

13 

Gazal S, Espinoza JR, Austerlitz F, Marchant D, Macarlupu JL, Rodriguez J, Ju-Preciado H, Rivera-Chira M, Hermine O, Leon-Velarde F, et al: The genetic architecture of chronic mountain sickness in Peru. Front Genet. 10:6902019. View Article : Google Scholar : PubMed/NCBI

14 

Simpson LL, Meah VL, Steele AR, Gasho C, Howe CA, Dawkins TG, Busch SA, Oliver SJ, Moralez G, Lawley JS, et al: Global REACH 2018: Andean highlanders, chronic mountain sickness and the integrative regulation of resting blood pressure. Exp Physiol. 106:104–116. 2021. View Article : Google Scholar

15 

Bermudez D, Azad P, Figueroa-Mujíca R, Vizcardo-Galindo G, Corante N, Guerra-Giraldez C, Haddad GG and Villafuerte FC: Increased hypoxic proliferative response and gene expression in erythroid progenitor cells of Andean highlanders with chronic mountain sickness. Am J Physiol Regul Integr Comp Physiol. 318:R49–R56. 2020. View Article : Google Scholar :

16 

Azad P, Zhou D, Tu HC, Villafuerte FC, Traver D, Rana TM and Haddad GG: Long noncoding RNA HIKER regulates erythropoiesis in Monge's disease via CSNK2B. J Clin Invest. 133:e1658312023. View Article : Google Scholar : PubMed/NCBI

17 

Crawford JE, Amaru R, Song J, Julian CG, Racimo F, Cheng JY, Guo X, Yao J, Ambale-Venkatesh B, Lima JA, et al: Natural selection on genes related to cardiovascular health in highaltitude adapted andeans. Am J Hum Genet. 101:752–767. 2017. View Article : Google Scholar : PubMed/NCBI

18 

He Y, Cui C, Guo Y, Zheng W, Yue T, Zhang H, Ouzhuluobu, Wu T, Qi X and Su B: High arterial oxygen saturation in the acclimatized lowlanders living at high altitude. Phenomics. 3:329–332. 2023. View Article : Google Scholar : PubMed/NCBI

19 

Zhao C, Li Z, Ji L, Ma J, Ge RL and Cui S: PI3K-Akt signal transduction molecules maybe involved in downregulation of erythroblasts apoptosis and perifosine increased its apoptosis in chronic mountain sickness. Med Sci Monit. 23:5637–5649. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Ma J, Ji L, Li Z, Liu H, Zhao C, Xiong H, Wang S, Ge RL and Cui S: Downregulation of intrinsic apoptosis pathway in erythroblasts contributes to excessive erythrocytosis of chronic mountain sickness. Blood Cells Mol Dis. 76:25–31. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Chen Z, Dong Z, Zeng R, Xu M, Zhang Y, Dan Q and Wang G: Association between single nucleotide polymorphisms in EPAS1 and PPARA genes and high altitude polycythemia in Chinese Tibetan population. Front Genet. 16:15191082025. View Article : Google Scholar : PubMed/NCBI

22 

Chen ZY, Wang L, Asavaritkrai P and Noguchi CT: Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning. J Neurosci Res. 88:3180–3188. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Myllymäki MNM, Määttä J, Dimova EY, Izzi V, Väisänen T, Myllyharju J, Koivunen P and Serpi R: Notch downregulation and extramedullary erythrocytosis in hypoxia-inducible factor prolyl 4-hydroxylase 2-deficient mice. Mol Cell Biol. 37:e00529–16. 2017. View Article : Google Scholar :

24 

Kwak J, Kim JH, Jang HN, Jung MH, Cho HS, Chang SH and Kim HJ: Erythropoietin ameliorates ischemia/reperfusion-induced acute kidney injury via inflammasome suppression in mice. Int J Mol Sci. 21:34532020. View Article : Google Scholar : PubMed/NCBI

25 

Greenwald AC, Licht T, Kumar S, Oladipupo SS, Iyer S, Grunewald M and Keshet E: VEGF expands erythropoiesis via hypoxia-independent induction of erythropoietin in noncanonical perivascular stromal cells. J Exp Med. 216:215–230. 2019. View Article : Google Scholar :

26 

Flygare J, Rayon Estrada V, Shin C, Gupta S and Lodish HF: HIF1alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal. Blood. 117:3435–3444. 2011. View Article : Google Scholar

27 

Lee J, Dey S, Rajvanshi PK, Merling RK, Teng R, Rogers HM and Noguchi CT: Neuronal nitric oxide synthase is required for erythropoietin stimulated erythropoiesis in mice. Front Cell Dev Biol. 11:11441102023. View Article : Google Scholar : PubMed/NCBI

28 

Schmidt WFJ, Wachsmuth NB, Romero Pozo MC, Aguilar Valerio MT, Contreras Tapia IC, Vater M, Kaufmann J, Jimenez-Claros JC and Soria R: Possible strategies to reduce altitude-related excessive polycythemia. J Appl Physiol (1985). 134:1321–1331. 2023. View Article : Google Scholar : PubMed/NCBI

29 

Goetze O, Schmitt J, Spliethoff K, Theurl I, Weiss G, Swinkels DW, Tjalsma H, Maggiorini M, Krayenbühl P, Rau M, et al: Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers. Hepatology. 58:2153–2162. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Xiang J, Wu DC, Chen Y and Paulson RF: In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors. Blood. 125:1803–1812. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Xu Y, Wang B, Zhang M, Zhang J, Li Y, Jia P, Zhang H, Duan L, Li Y, Li Y, et al: Carbon dots as a potential therapeutic agent for the treatment of cancer-related anemia. Adv Mater. 34:e22009052022. View Article : Google Scholar : PubMed/NCBI

32 

Singh RP, Grinenko T, Ramasz B, Franke K, Lesche M, Dahl A, Gassmann M, Chavakis T, Henry I and Wielockx B: Hematopoietic stem cells but not multipotent progenitors drive erythropoiesis during chronic erythroid stress in EPO transgenic mice. Stem Cell Reports. 10:1908–1919. 2018. View Article : Google Scholar : PubMed/NCBI

33 

Villafuerte FC, Corante N, Anza-Ramírez C, Figueroa-Mujíca R, Vizcardo-Galindo G, Mercado A, Macarlupú JL and León-Velarde F: Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with chronic mountain sickness. J Appl Physiol (1985). 121:53–58. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Liu YS, Huang H, Zhou SM, Tian HJ and Li P: Excessive iron availability caused by disorders of interleukin-10 and interleukin-22 contributes to high altitude polycythemia. Front Physiol. 9:5482018. View Article : Google Scholar : PubMed/NCBI

35 

Anderson ER, Taylor M, Xue X, Martin A, Moons DS, Omary MB and Shah YM: The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression. Mol Cell Biol. 32:4068–4077. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S and Peyssonnaux C: HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest. 119:1159–1166. 2009. View Article : Google Scholar : PubMed/NCBI

37 

Schwartz AJ, Das NK, Ramakrishnan SK, Jain C, Jurkovic MT, Wu J, Nemeth E, Lakhal-Littleton S, Colacino JA and Shah YM: Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload. J Clin Invest. 129:336–348. 2019. View Article : Google Scholar :

38 

Płoszczyca K, Czuba M, Chalimoniuk M, Witek K and Baranowski M: Hepcidin and erythroferrone response to 3 weeks of exposure to normobaric hypoxia at rest in trained cyclists. Front Physiol. 14:12798272023. View Article : Google Scholar

39 

Lakhal S, Schödel J, Townsend AR, Pugh CW, Ratcliffe PJ and Mole DR: Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: New link between hypoxia signaling and iron homeostasis. J Biol Chem. 286:4090–4097. 2011. View Article : Google Scholar

40 

Maurer E, Gütschow M and Stirnberg M: Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: Identification of a hypoxia-responsive element in the TMPRSS6 promoter region. Biol Chem. 393:535–540. 2012. View Article : Google Scholar : PubMed/NCBI

41 

Heritage ML, Murphy TL, Bridle KR, Anderson GJ, Crawford DH and Fletcher LM: Hepcidin regulation in wild-type and Hfe knockout mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response. Alcohol Clin Exp Res. 33:1391–1400. 2009. View Article : Google Scholar : PubMed/NCBI

42 

Chiabrando D, Fiorito V, Marro S, Silengo L, Altruda F and Tolosano E: Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice. Blood Cells Mol Dis. 50:25–30. 2013. View Article : Google Scholar

43 

Kremyanskaya M, Kuykendall AT, Pemmaraju N, Ritchie EK, Gotlib J, Gerds A, Palmer J, Pettit K, Nath UK, Yacoub A, et al: Rusfertide, a hepcidin mimetic, for control of erythrocytosis in polycythemia vera. N Engl J Med. 390:723–735. 2024. View Article : Google Scholar : PubMed/NCBI

44 

Modi NB, Khanna S, Rudraraju S and Valone F: Pharmacokinetics and pharmacodynamics of rusfertide, a hepcidin mimetic, following subcutaneous administration of a lyophilized powder formulation in healthy volunteers. Drugs R D. 24:539–552. 2024. View Article : Google Scholar : PubMed/NCBI

45 

Jain C, Parimi S, Huang W, Hannifin S, Singhal R, Das NK, Lee KE and Shah YM: Myeloid Hif2α is not essential to maintain systemic iron homeostasis. Exp Hematol. 125-126:25–36.e1. 2023. View Article : Google Scholar

46 

Del Balzo U, Signore PE, Walkinshaw G, Seeley TW, Brenner MC, Wang Q, Guo G, Arend MP, Flippin LA, Chow FA, et al: Nonclinical characterization of the hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat, a novel treatment of anemia of chronic kidney disease. J Pharmacol Exp Ther. 374:342–353. 2020. View Article : Google Scholar : PubMed/NCBI

47 

Yan P, Li N, Ma M, Liu Z, Yang H, Li J, Wan C, Gao S, Li S, Zheng L, et al: Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis. Signal Transduct Target Ther. 8:3552023. View Article : Google Scholar : PubMed/NCBI

48 

Zhang W, Jiao L, Liu R, Zhang Y, Ji Q, Zhang H, Gao X, Ma Y and Shi HN: The effect of exposure to high altitude and low oxygen on intestinal microbial communities in mice. PLoS One. 13:e02037012018. View Article : Google Scholar : PubMed/NCBI

49 

Han Y, Xu J, Yan Y and Zhao X: Dynamics of the gut microbiota in rats after hypobaric hypoxia exposure. PeerJ. 10:e140902022. View Article : Google Scholar : PubMed/NCBI

50 

Zhu LL, Ma ZJ, Ren M, Wei YM, Liao YH, Shen YL, Fan SM, Li L, Wu QX, Gao ZS, et al: Distinct features of gut microbiota in high-altitude tibetan and middle-altitude han hypertensive patients. Cardiol Res Pract. 2020:19578432020. View Article : Google Scholar : PubMed/NCBI

51 

Liang T, Liu F, Ma L, Zhang Z, Liu L, Huang T, Li J, Dong W, Zhang H, Li Y, et al: Migration effects on the intestinal microbiota of Tibetans. PeerJ. 9:e120362021. View Article : Google Scholar : PubMed/NCBI

52 

Šket R, Debevec T, Kublik S, Schloter M, Schoeller A, Murovec B, Vogel Mikuš K, Makuc D, Pečnik K, Plavec J, et al: Intestinal metagenomes and metabolomes in healthy young males: Inactivity and hypoxia generated negative physiological symptoms precede microbial dysbiosis. Front Physiol. 9:1982018. View Article : Google Scholar : PubMed/NCBI

53 

Zhang Y, Luo H, Niu Y, Yang X, Li Z, Wang K, Bi H and Pang X: Chronic intermittent hypoxia induces gut microbial dysbiosis and infers metabolic dysfunction in mice. Sleep Med. 91:84–92. 2022. View Article : Google Scholar : PubMed/NCBI

54 

Wang RX, Henen MA, Lee JS, Vögeli B and Colgan SP: Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor. Gut Microbes. 13:19383802021. View Article : Google Scholar : PubMed/NCBI

55 

Ornelas A, Welch N, Countess JA, Zhou L, Wang RX, Dowdell AS and Colgan SP: Mimicry of microbially-derived butyrate reveals templates for potent intestinal epithelial HIF stabilizers. Gut Microbes. 15:22677062023. View Article : Google Scholar : PubMed/NCBI

56 

Zhou C, Li L, Li T, Sun L, Yin J, Guan H, Wang L, Zhu H, Xu P, Fan X, et al: SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α. J Mol Med (Berl). 98:1189–1202. 2020. View Article : Google Scholar : PubMed/NCBI

57 

Bereded NK, Abebe GB, Fanta SW, Curto M, Waidbacher H, Meimberg H and Domig KJ: The gut bacterial microbiome of Nile tilapia (Oreochromis niloticus) from lakes across an altitudinal gradient. BMC Microbiol. 22:872022. View Article : Google Scholar : PubMed/NCBI

58 

Hu C, Wang P, Yang Y, Li J, Jiao X, Yu H, Wei Y, Li J and Qin Y: Chronic intermittent hypoxia participates in the pathogenesis of atherosclerosis and perturbs the formation of intestinal microbiota. Front Cell Infect Microbiol. 11:5602012021. View Article : Google Scholar

59 

Li C and Shi S: Gut microbiota and metabolic profiles in chronic intermittent hypoxia-induced rats: Disease-associated dysbiosis and metabolic disturbances. Front Endocrinol (Lausanne). 14:12243962023. View Article : Google Scholar

60 

Chen A, Teng C, Wei J, Wu X, Zhang H, Chen P, Cai D, Qian H, Zhu H, Zheng X and Chen X: Gut microbial dysbiosis exacerbates long-term cognitive impairments by promoting intestinal dysfunction and neuroinflammation following neonatal hypoxia-ischemia. Gut Microbes. 17:24710152025. View Article : Google Scholar : PubMed/NCBI

61 

Khanna K, Mishra KP, Chanda S, Ganju L, Singh SB and Kumar B: Effect of synbiotics on amelioration of intestinal inflammation under hypobaric hypoxia. High Alt Med Biol. 22:32–44. 2021. View Article : Google Scholar

62 

Hu J, Lang H, Fan D, Wen T, Shi J, Xiao C, Li Y, Kang C, Shi P, Shen L and Lin N: Curcumin supplementation accelerates high-altitude acclimatization, prevents polycythemia and modulates gut microbiota in male Han population: A randomized controlled trial. Front Nutr. 12:15723762025. View Article : Google Scholar : PubMed/NCBI

63 

Rao J, Li J, Liu Y, Lu P, Sun X, Sugumaran PK and Zhu D: The key role of PGC-1α in mitochondrial biogenesis and the proliferation of pulmonary artery vascular smooth muscle cells at an early stage of hypoxic exposure. Mol Cell Biochem. 367:9–18. 2012. View Article : Google Scholar : PubMed/NCBI

64 

Song K, Zhang Y, Ga Q, Bai Z and Ge RL: Increased insulin sensitivity by high-altitude hypoxia in mice with high-fat diet-induced obesity is associated with activated AMPK signaling and subsequently enhanced mitochondrial biogenesis in skeletal muscles. Obes Facts. 13:455–472. 2020. View Article : Google Scholar : PubMed/NCBI

65 

Qian X, Li X, Shi Z, Bai X, Xia Y, Zheng Y, Xu D, Chen F, You Y, Fang J, et al: KDM3A senses oxygen availability to regulate PGC-1α-mediated mitochondrial biogenesis. Mol Cell. 76:885–895.e7. 2019. View Article : Google Scholar

66 

Sharma J, Johnston MV and Hossain MA: Sex differences in mitochondrial biogenesis determine neuronal death and survival in response to oxygen glucose deprivation and reoxygenation. BMC Neurosci. 15:92014. View Article : Google Scholar : PubMed/NCBI

67 

Yan W, Zhang H, Liu P, Wang H, Liu J, Gao C, Liu Y, Lian K, Yang L, Sun L, et al: Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart. Basic Res Cardiol. 108:3292013. View Article : Google Scholar

68 

Pak O, Scheibe S, Esfandiary A, Gierhardt M, Sydykov A, Logan A, Fysikopoulos A, Veit F, Hecker M, Kroschel F, et al: Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension. Eur Respir J. 51:17010242018. View Article : Google Scholar : PubMed/NCBI

69 

Ahmed ASI, Blood AB and Zhang L: MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux. Acta Physiol (Oxf). 240:e142122024. View Article : Google Scholar : PubMed/NCBI

70 

Li S, Lyu Q, Shi Q, Bai Y, Ren X and Ma J: Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-γ axis. Clin Sci (Lond). 138:103–115. 2024. View Article : Google Scholar : PubMed/NCBI

71 

Chitra L and Boopathy R: Altered mitochondrial biogenesis and its fusion gene expression is involved in the high-altitude adaptation of rat lung. Respir Physiol Neurobiol. 192:74–84. 2014. View Article : Google Scholar

72 

Yang L, Ye F, Zeng L, Li Y and Chai W: Knockdown of HMGB1 suppresses hypoxia-induced mitochondrial biogenesis in pancreatic cancer cells. Onco Targets Ther. 13:1187–1198. 2020. View Article : Google Scholar : PubMed/NCBI

73 

Xu Y, Wang P, Hu T, Ning K and Bao Y: Notoginsenoside R1 attenuates H/R injury in H9c2 cells by maintaining mitochondrial homeostasis. Curr Issues Mol Biol. 47:442025. View Article : Google Scholar : PubMed/NCBI

74 

Yuan ZJ, Xiao Y, Liu Z, Zhang AQ, Li B and Gao SX: Effect of total secondary ginsenosides on apoptosis and energy metabolism of H9c2 cells under hypoxia based on mitochondrial biogenesis. Zhongguo Zhong Yao Za Zhi. 50:1255–1266. 2025.In Chinese. PubMed/NCBI

75 

Chai N, Zheng H, Zhang H, Li L, Yu X, Wang L, Bi X, Yang L, Niu T, Liu X, et al: Spermidine alleviates intrauterine hypoxia-induced offspring newborn myocardial mitochondrial damage in rats by inhibiting oxidative stress and regulating mitochondrial quality control. Iran J Pharm Res. 21:e1337762023. View Article : Google Scholar : PubMed/NCBI

76 

Strapazzon G, Malacrida S, Vezzoli A, Dal Cappello T, Falla M, Lochner P, Moretti S, Procter E, Brugger H and Mrakic-Sposta S: Oxidative stress response to acute hypobaric hypoxia and its association with indirect measurement of increased intracranial pressure: A field study. Sci Rep. 6:324262016. View Article : Google Scholar : PubMed/NCBI

77 

Zhang P, Li Z, Yang F, Ji L, Yang Y, Liu C, Liu H, Ma J, Liu J, Dang Z, et al: Novel insights into plasma biomarker candidates in patients with chronic mountain sickness based on proteomics. Biosci Rep. 41:BSR202022192021. View Article : Google Scholar : PubMed/NCBI

78 

Song J, Yoon D, Christensen RD, Horvathova M, Thiagarajan P and Prchal JT: HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis. J Mol Med (Berl). 93:857–866. 2015. View Article : Google Scholar : PubMed/NCBI

79 

Kuhikar R, Khan N, Philip J, Melinkeri S, Kale V and Limaye L: Transforming growth factor β1 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy. Stem Cell Res Ther. 11:712020. View Article : Google Scholar

80 

Yang M, Wen T, Chen H, Deng J, Yang C and Zhang Z: Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: Role of autophagy. Stem Cell Res Ther. 9:2842018. View Article : Google Scholar : PubMed/NCBI

81 

Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, Prchal JT, Chen M and Wang J: Essential role for Nix in autophagic maturation of erythroid cells. Nature. 454:232–235. 2008. View Article : Google Scholar : PubMed/NCBI

82 

Zhang J and Ney PA: NIX induces mitochondrial autophagy in reticulocytes. Autophagy. 4:354–356. 2008. View Article : Google Scholar : PubMed/NCBI

83 

Zhang J and Ney PA: Reticulocyte mitophagy: Monitoring mitochondrial clearance in a mammalian model. Autophagy. 6:405–408. 2010. View Article : Google Scholar : PubMed/NCBI

84 

Yuan Y, Zheng Y, Zhang X, Chen Y, Wu X, Wu J, Shen Z, Jiang L, Wang L, Yang W, et al: BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2. Autophagy. 13:1754–1766. 2017. View Article : Google Scholar : PubMed/NCBI

85 

Sagrillo-Fagundes L, Bienvenue-Pariseault J and Vaillancourt C: Melatonin: The smart molecule that differentially modulates autophagy in tumor and normal placental cells. PLoS One. 14:e02024582019. View Article : Google Scholar : PubMed/NCBI

86 

Lin Z, Lu Y, Yu G, Teng H, Wang B, Yang Y, Li Q, Sun Z, Xu S, Wang W and Tian P: Genome-wide DNA methylation landscape of four Chinese populations and epigenetic variation linked to Tibetan high-altitude adaptation. Sci China Life Sci. 66:2354–2369. 2023. View Article : Google Scholar : PubMed/NCBI

87 

Zhaxi Q, Gesang L, Huang J, Suona Y, Ci B, Danzeng Z, Zhang R and Liu B: Hypermethylation of BMPR2 and TGF-β promoter regions in tibetan patients with high-altitude polycythemia at extreme altitude. Biochem Genet. 63:2409–2421. 2025. View Article : Google Scholar

88 

Zheng GP, Nian W, Shi XF and Xie YB: Progress in multiomics research on high altitude polycythemia. Zhonghua Xue Ye Xue Za Zhi. 45:795–800. 2024.In Chinese. PubMed/NCBI

89 

Chen YC, Hsu PY, Chin CH, Hsiao CC, Liou CW, Wang TY, Lin YY, Lee CP, Lin HC, Lin MC and Su MC: H3K23/H3K36 hypoacetylation and HDAC1 up-regulation are associated with adverse consequences in obstructive sleep apnea patients. Sci Rep. 11:206972021. View Article : Google Scholar : PubMed/NCBI

90 

Matsui H, Iriyama T, Sayama S, Inaoka N, Suzuki K, Yoshikawa M, Ichinose M, Sone K, Kumasawa K, Nagamatsu T, et al: Elevated placental histone H3K4 methylation via upregulated histone methyltransferases SETD1A and SMYD3 in preeclampsia and its possible involvement in hypoxia-induced pathophysiological process. Placenta. 115:60–69. 2021. View Article : Google Scholar : PubMed/NCBI

91 

Narayanan S, Eliasson Angelstig S, Xu C, Grünler J, Zhao A, Zhu W, Xu Landén N, Ståhle M, Zhang J, Ivan M, et al: HypoxamiR-210 accelerates wound healing in diabetic mice by improving cellular metabolism. Commun Biol. 3:7682020. View Article : Google Scholar : PubMed/NCBI

92 

Wang S, Ma J, Qiu H, Liu S, Zhang S, Liu H, Zhang P, Ge RL, Li G and Cui S: Plasma exosomal microRNA expression profiles in patients with high-altitude polycythemia. Blood Cells Mol Dis. 98:1027072023. View Article : Google Scholar

93 

Liu F, Hu C, Ding J, Fu C, Wang S and Li T: GATA-1 promotes erythroid differentiation through the upregulation of miR-451a and miR-210-3p expressions in CD34+ cells in high-altitude polycythemia. High Alt Med Biol. 24:59–67. 2023. View Article : Google Scholar : PubMed/NCBI

94 

Chen YC, Hsu PY, Su MC, Chin CH, Liou CW, Wang TY, Lin YY, Lee CP, Lin MC and Hsiao CC: miR-21-5p under-expression in patients with obstructive sleep apnea modulates intermittent hypoxia with re-oxygenation-induced-cell apoptosis and cytotoxicity by targeting pro-inflammatory TNF-α-TLR4 signaling. Int J Mol Sci. 21:9992020. View Article : Google Scholar

95 

Chen Y, Zeng H and Liu H: MiR-21 participates in the neuroprotection of diazoxide against hypoxic-ischemia encephalopathy by targeting PDCD4. Brain Inj. 36:876–885. 2022. View Article : Google Scholar : PubMed/NCBI

96 

Tayae E, Amr E, Zaki A and Elkaffash D: LncRNA HIF1A-AS2: A potential biomarker for early diagnosis of acute myocardial infarction and predictor of left ventricular dysfunction. BMC Cardiovasc Disord. 23:1352023. View Article : Google Scholar : PubMed/NCBI

97 

Tian P, Xu Z, Guo J, Zhao J, Chen W, Huang W, Wang M, Mi C, Zhang Y, Yang Y and Zhang H: Hypoxia causes trophoblast cell ferroptosis to induce miscarriage through lnc-HZ06/HIF1α-SUMO/NCOA4 axis. Redox Biol. 70:1030732024. View Article : Google Scholar

98 

Bhadury J, Einarsdottir BO, Podraza A, Bagge RO, Stierner U, Ny L, Dávila López M and Nilsson JA: Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts. Oncotarget. 7:23801–23811. 2016. View Article : Google Scholar : PubMed/NCBI

99 

Teramo KA, Klemetti MM and Widness JA: Robust increases in erythropoietin production by the hypoxic fetus is a response to protect the brain and other vital organs. Pediatr Res. 84:807–812. 2018. View Article : Google Scholar : PubMed/NCBI

100 

Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J and Xiang J: Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer. 18:402019. View Article : Google Scholar : PubMed/NCBI

101 

Ikeda S, Kitadate A, Abe F, Saitoh H, Michishita Y, Hatano Y, Kawabata Y, Kitabayashi A, Teshima K, Kume M, et al: Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma. Cancer Sci. 108:641–652. 2017. View Article : Google Scholar : PubMed/NCBI

102 

Wang Z, Liu Y, Shao M, Wang D and Zhang Y: Combined prediction of miR-210 and miR-374a for severity and prognosis of hypoxic-ischemic encephalopathy. Brain Behav. 8:e008352017. View Article : Google Scholar

103 

Afsar S, Syed RU, Bin Break MK, Alsukaybi RH, Alanzi RA, Alshobrmi AM, Alshagdali NM, Alshammari AD, Alharbi FM, Alshammari AM, et al: The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling. Pathol Res Pract. 253:1550182024. View Article : Google Scholar

104 

Vonkova B, Blahakova I, Hruban L, Janku P and Pospisilova S: MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 163:259–264. 2019. View Article : Google Scholar

105 

Ma Y, Zhou Y, Xiao Q, Zou SS, Zhu YC, Ping P and Chen XF: Seminal exosomal miR-210-3p as a potential marker of Sertoli cell damage in varicocele. Andrology. 9:451–459. 2021. View Article : Google Scholar

106 

Vangrieken P, Remels AHV, Al-Nasiry S, Bast A, Janssen GMJ, von Rango U, Vroomans D, Pinckers YCW, van Schooten FJ and Schiffers PMH: Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity. Hypertens Res. 43:1361–1374. 2020. View Article : Google Scholar : PubMed/NCBI

107 

Li Y, Wang C, Ma H and Wang M: Multi-omics analysis reveals the molecular mechanisms and therapeutic targets in high altitude polycythemia. Ann Biol Clin (Paris). 83:20–34. 2025.PubMed/NCBI

108 

Agrawal A, Rathor R and Suryakumar G: Oxidative protein modification alters proteostasis under acute hypobaric hypoxia in skeletal muscles: A comprehensive in vivo study. Cell Stress Chaperones. 22:429–443. 2017. View Article : Google Scholar : PubMed/NCBI

109 

Zhuan B, Wang X, Wang MD, Li ZC, Yuan Q, Xie J and Yang Z: Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress. Aging (Albany NY). 12:23684–23697. 2020. View Article : Google Scholar : PubMed/NCBI

110 

Laban H, Siegmund S, Zappe M, Trogisch FA, Heineke J, Torre C, Fisslthaler B, Arnold C, Lauryn J, Büttner M, et al: NFAT5/TonEBP limits pulmonary vascular resistance in the hypoxic lung by controlling mitochondrial reactive oxygen species generation in arterial smooth muscle cells. Cells. 10:32932021. View Article : Google Scholar : PubMed/NCBI

111 

Sang D, Wang K, Sun X, Wang Y, Lin H, Jia R and Qu F: NIR-driven intracellular photocatalytic O2 evolution on Z-scheme Ni3S2/Cu1.8S@HA for hypoxic tumor therapy. ACS Appl Mater Interfaces. 13:9604–9619. 2021. View Article : Google Scholar : PubMed/NCBI

112 

Yang R, Huang J, Liao M, Huang J, Gao B, Zhang H, Zhou J, Xu J and Lu Q: An oxygen-sufficient nanoplatform for enhanced imaging-guided microwave dynamic therapy against hypoxic tumors. Int J Nanomedicine. 17:5525–5545. 2022. View Article : Google Scholar : PubMed/NCBI

113 

Chen J, Tang Q, Wang Y, Xu M, Sun S, Zhang J, Wu R, Yue X, Li X, Chen Q and Liang X: Ultrasound-induced piezocatalysis triggered NO generation for enhanced hypoxic tumor therapy. ACS Appl Mater Interfaces. 15:15220–15234. 2023. View Article : Google Scholar : PubMed/NCBI

114 

Zhao H, Sun L, Liu J, Shi B, Zhang Y, Qu-Zong CR, Dorji T, Wang T, Yuan H and Yang J: Meta-analysis identifying gut microbial biomarkers of Qinghai-Tibet Plateau populations and the functionality of microbiota-derived butyrate in high-altitude adaptation. Gut Microbes. 16:23501512024. View Article : Google Scholar : PubMed/NCBI

115 

Bakshi J and Mishra KP: Identification of biomarkers for gastrointestinal barrier injury and protective role of sodium butyrate in hypobaric hypoxia exposed rats. Int Immunopharmacol. 165:1154242025. View Article : Google Scholar : PubMed/NCBI

116 

Pan C, Chen Z, Li C, Han T, Liu H and Wang X: Sestrin2 as a gatekeeper of cellular homeostasis: Physiological effects for the regulation of hypoxia-related diseases. J Cell Mol Med. 25:5341–5350. 2021. View Article : Google Scholar : PubMed/NCBI

117 

Ali Sheikh MS: The mir-21 inhibition enhanced HUVEC cellular viability during hypoxia-reoxygenation injury by regulating PDCD4. Mediators Inflamm. 2022:96619402022. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li H, Zhang H, Zhang H, Li Y, He Y and Luan J: High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review). Int J Mol Med 57: 164, 2026.
APA
Li, H., Zhang, H., Zhang, H., Li, Y., He, Y., & Luan, J. (2026). High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review). International Journal of Molecular Medicine, 57, 164. https://doi.org/10.3892/ijmm.2026.5835
MLA
Li, H., Zhang, H., Zhang, H., Li, Y., He, Y., Luan, J."High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review)". International Journal of Molecular Medicine 57.6 (2026): 164.
Chicago
Li, H., Zhang, H., Zhang, H., Li, Y., He, Y., Luan, J."High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review)". International Journal of Molecular Medicine 57, no. 6 (2026): 164. https://doi.org/10.3892/ijmm.2026.5835
Copy and paste a formatted citation
x
Spandidos Publications style
Li H, Zhang H, Zhang H, Li Y, He Y and Luan J: High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review). Int J Mol Med 57: 164, 2026.
APA
Li, H., Zhang, H., Zhang, H., Li, Y., He, Y., & Luan, J. (2026). High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review). International Journal of Molecular Medicine, 57, 164. https://doi.org/10.3892/ijmm.2026.5835
MLA
Li, H., Zhang, H., Zhang, H., Li, Y., He, Y., Luan, J."High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review)". International Journal of Molecular Medicine 57.6 (2026): 164.
Chicago
Li, H., Zhang, H., Zhang, H., Li, Y., He, Y., Luan, J."High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review)". International Journal of Molecular Medicine 57, no. 6 (2026): 164. https://doi.org/10.3892/ijmm.2026.5835
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team